全文获取类型
收费全文 | 761篇 |
免费 | 43篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 45篇 |
妇产科学 | 2篇 |
基础医学 | 83篇 |
口腔科学 | 16篇 |
临床医学 | 71篇 |
内科学 | 123篇 |
皮肤病学 | 20篇 |
神经病学 | 117篇 |
特种医学 | 123篇 |
外科学 | 79篇 |
综合类 | 15篇 |
预防医学 | 39篇 |
眼科学 | 1篇 |
药学 | 26篇 |
肿瘤学 | 62篇 |
出版年
2021年 | 13篇 |
2020年 | 4篇 |
2019年 | 9篇 |
2018年 | 8篇 |
2017年 | 10篇 |
2016年 | 9篇 |
2015年 | 16篇 |
2014年 | 15篇 |
2013年 | 21篇 |
2012年 | 14篇 |
2011年 | 19篇 |
2010年 | 39篇 |
2009年 | 40篇 |
2008年 | 19篇 |
2007年 | 38篇 |
2006年 | 30篇 |
2005年 | 22篇 |
2004年 | 22篇 |
2003年 | 8篇 |
2002年 | 15篇 |
2001年 | 18篇 |
2000年 | 6篇 |
1999年 | 14篇 |
1998年 | 35篇 |
1997年 | 39篇 |
1996年 | 36篇 |
1995年 | 29篇 |
1994年 | 13篇 |
1993年 | 20篇 |
1992年 | 4篇 |
1991年 | 10篇 |
1990年 | 13篇 |
1989年 | 22篇 |
1988年 | 23篇 |
1987年 | 17篇 |
1986年 | 14篇 |
1985年 | 13篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 14篇 |
1981年 | 5篇 |
1980年 | 12篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1971年 | 5篇 |
1943年 | 4篇 |
1935年 | 3篇 |
排序方式: 共有825条查询结果,搜索用时 745 毫秒
1.
2.
3.
4.
5.
Prolonged exposure to host immunity was studied for its effect on several characteristics of a cloned 3-methylcholanthrene-induced fibrosarcoma. One million cells of a clone 10-O were injected subcutaneously into normal C3H/HeJ mice (clone 10-N) or tumor-immune mice (clone 10-I). After 10 passages in immune mice, 1 X 10(6) cells from 10-I tumor were transferred back into normal mice (clone 10-R). After 5 to 10 additional in vivo passages, clone 10-O, 10-N, 10-I, and 10-R tumors were transplanted into normal mice and observed for tumor growth rate, tumorigenicity, antigen specificity, metastatic potential, and plating efficiency. Clone 10-I after 10 passages in immunized mice grew significantly more slowly than did 10-O or 10-N clones, required more tumor cells to cause 50% tumor incidence in normal mice (tumorigenicity), and completely lost its capacity to metastasize spontaneously or experimentally. The plating efficiency in vitro of 10-I was also less than that of 10-O or 10-N. All these changes reversed after 5 to 10 passages of 10-I clone back into normal mice (10-R). Although immune pressure induced qualitative antigenic changes, as demonstrated by a tumor-rejection assay, and resulted in no cross-reactivity with control tumor clones (antigen specificity), the degree of immune response to its autologous clone in immune mice (immunogenicity) remained constant. These results suggest that several unrelated characteristics of this clone 10 can be phenotypically changed during the same period by immune pressure. 相似文献
6.
Shearwood McClelland Patrick B Senatus Blair Ford Guy M McKhann Robert R Goodman 《Journal of clinical neuroscience》2007,14(8):791-793
Deep brain stimulation (DBS) for medically intractable Parkinson's disease (PD) is well established, but carries the inconveniences of frame-based neurosurgery. Previous reports have demonstrated that ventricular shunt placement and some functional procedures can be accurately performed using frameless stereotaxy. We present a report indicating that staged deep brain electrode placement can be accurate and efficacious using a frameless skull-mounted guide. 相似文献
7.
Kinnison ML; Perler BA; Kaufman SL; Mitchell SE; Kadir S; Williams GM; White RI Jr 《Radiology》1986,160(3):727-730
In situ saphenous vein grafts are being used with increasing frequency for bypass procedures involving the femoral and popliteal arteries. Complications of these procedures include anastomotic stenoses and persistent arteriovenous fistulae that may result in failure of the graft. Balloon angioplasty and embolotherapy with detachable balloons were employed successfully in three or four recent cases of patients with complications from in situ grafts. Tailored angiography is essential for evaluating in situ grafts, and interventional techniques are extremely useful for managing complications. 相似文献
8.
9.
Polycystic kidney disease is an autosomal dominant disease that may be associated with cystic disease of the liver. In women, the cysts may develop early and be more troublesome than in men. Cystadenocarcinoma of the pancreas is uncommon, comprising 1% of primary pancreatic malignancies. This case report is the first to describe a familial association between polycystic kidney disease and cystadenocarcinoma of the pancreas and liver in the English medical literature. A patient with autosomal dominant polycystic kidney disease (ADPKD) and multiple hepatic cysts developed cystadenocarcinoma of the pancreas with multiple malignant liver cysts. The patient's mother, sister, and niece had ADPKD, and the patient's sister also died of pancreatic cystadenocarcinoma. We believe that the development of these two disease entities in which the primary pathology is cyst formation has a genetic association. (Gastroenterology 1997 Jun;112(6):2104-7) 相似文献
10.
Bruce G. Haffty M.D. Peter L. Perrotta M.D. † Barbara Ward M.D. ‡ Meena Moran M.D. Malcolm Beinfield M.D. ‡ Charles McKhann M.D. ‡ Diana Fischer Ph.D. Darryl Carter M.D. † 《The breast journal》1997,3(1):7-14
Abstract: Between 1970 and 1990, 1,008 patients with early-stage breast cancer were treated by conservative surgery without axillary dissection followed by radiation therapy to the intact breast in the Department of Therapeutic Radiology at Yale-New Haven Hospital. The patient population, broken down by histologic subtype, was as follows: 761 patients presented with infiltrating ductal carcinoma, 70 patients with pure intraductal, 38 intraductal with focal invasion, 54 infiltrating lobular, 21 tubular, 17 medullary, 16 mucinous, and 29 with other various histologic subtypes. Patients were followed on a regular basis by the referring physicians and radiation oncologists. Diagnostic studies for distant metastases were performed as clinically indicated. Annual mammography was a routine component of the follow-up program. As of 3/96, with a median follow-up of 10.5 years, 83 patients developed an ipsilateral breast tumor recurrence, and 109 patients developed distant metastases resulting in an overall 10-year breast recurrence-free rate of 84%, and a 10-year distant metastasis-free rate of 78%. There were significant differences in clinical stage, pathological nodal involvement, and administration of systemic therapy between various histologic subtypes. As expected, those patients with histologies of low metastatic potential (such as intraductal, tubular, and mucinous) had significantly superior distant recurrence-free survival rates. With respect to breast relapse rates, there were no statistically significant differences in the 5- and 10-year breast recurrence-free rates between any of the histologic subtypes. Patients with intraductal carcinoma with or without focal invasion had similar breast relapse rates as those with other histologic subtypes. Patients with lobular carcinoma in situ as a histologic component also had a similar overall breast relapse-free recurrence rate. In conclusion, long-term follow-up of conservatively treated breast cancer patients demonstrates no significant differences in ipsilateral breast tumor recurrence rates between various histologic subtypes. There are no histologies which had a statistically significantly higher breast-relapse rate than infiltrating ductal carcinomas and therefore no primary histologic subtype represents a relative contraindication to breast conservation therapy. 相似文献